Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strict Versus Permissive Thresholds for Insulin Initiation in Gestational Diabetes (START1)
NCT06419777Recruiting
- Sponsor
- Thomas Jefferson University
- Start
- Sep 2024
- Primary completion
- May 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of human insulin in gestational diabetes mellitus (GDM) (2 arms), sponsored by Thomas Jefferson University. Primary endpoint: Neonatal Composite Outcome. Started Sep 2024; status: recruiting.
02
Drugs
human insulin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT06419777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06419777.